Laboratorios Farmaceuticos Rovi, S.A. (BME: ROVI)
78.30
-0.25 (-0.32%)
Sep 4, 2024, 12:58 PM CET
ROVI Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 4,018 | 3,579 | 2,756 | 6,682 | 4,065 | 2,371 | Upgrade
|
Market Cap Growth | 11.35% | 29.84% | -58.75% | 64.37% | 71.46% | 24.86% | Upgrade
|
Enterprise Value | 4,101 | 4,881 | 4,163 | 7,629 | 4,654 | 3,052 | Upgrade
|
Last Close Price | 78.55 | 18.61 | 13.90 | 32.27 | 19.02 | 10.96 | Upgrade
|
PE Ratio | 28.15 | 31.01 | 16.39 | 24.37 | 38.27 | 255.84 | Upgrade
|
PS Ratio | 5.36 | 1.70 | 1.13 | 2.99 | 2.66 | 1.69 | Upgrade
|
PB Ratio | 8.81 | 2.27 | 1.64 | 4.12 | 2.85 | 1.64 | Upgrade
|
P/FCF Ratio | 109.67 | 9.16 | 39.02 | 22.29 | 15.04 | 18.41 | Upgrade
|
P/OCF Ratio | 8.09 | 8.34 | 22.92 | 19.50 | 13.92 | 15.24 | Upgrade
|
EV/Sales Ratio | 5.27 | 2.32 | 1.70 | 3.42 | 3.05 | 2.17 | Upgrade
|
EV/EBITDA Ratio | 18.51 | 14.71 | 10.02 | 16.45 | 17.67 | 14.77 | Upgrade
|
EV/EBIT Ratio | 21.52 | 20.71 | 13.32 | 19.90 | 25.01 | 37.83 | Upgrade
|
EV/FCF Ratio | 111.93 | 12.49 | 58.93 | 25.46 | 17.22 | 23.70 | Upgrade
|
Debt / Equity Ratio | 0.82 | 0.84 | 0.87 | 0.72 | 0.58 | 0.70 | Upgrade
|
Debt / EBITDA Ratio | 3.66 | 3.56 | 3.24 | 2.39 | 2.87 | 4.91 | Upgrade
|
Debt / FCF Ratio | 3.15 | 3.39 | 20.67 | 3.91 | 3.04 | 7.88 | Upgrade
|
Asset Turnover | 0.55 | 0.58 | 0.67 | 0.71 | 0.53 | 0.48 | Upgrade
|
Inventory Turnover | 1.90 | 1.96 | 2.20 | 2.73 | 2.67 | 2.67 | Upgrade
|
Quick Ratio | 0.87 | 0.83 | 0.65 | 0.45 | 1.21 | 1.52 | Upgrade
|
Current Ratio | 1.59 | 1.76 | 1.73 | 1.07 | 1.91 | 2.26 | Upgrade
|
Return on Equity (ROE) | 7.81% | 7.18% | 9.96% | 16.78% | 6.95% | 0.98% | Upgrade
|
Return on Assets (ROA) | 4.02% | 4.05% | 5.37% | 7.59% | 4.01% | 1.72% | Upgrade
|
Return on Capital (ROIC) | 5.11% | 4.88% | 6.58% | 9.50% | 4.94% | 2.09% | Upgrade
|
Earnings Yield | 3.55% | 3.18% | 5.80% | 3.78% | 2.37% | 0.35% | Upgrade
|
FCF Yield | 0.91% | 10.92% | 2.56% | 4.49% | 6.65% | 5.43% | Upgrade
|
Dividend Yield | 1.41% | 2.95% | 5.04% | 2.63% | 3.21% | - | Upgrade
|
Payout Ratio | 46.64% | 116.74% | 99.96% | 30.09% | 42.28% | - | Upgrade
|
Buyback Yield / Dilution | -0.76% | -0.56% | 1.03% | 1.74% | 0.18% | -27.56% | Upgrade
|
Total Shareholder Return | 0.64% | 2.39% | 6.07% | 4.38% | 3.39% | -27.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.